Viewing nowSimba Medi Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

MFDS item code 201402515 · Approved 2014.06.03 · Insurance code 625800130
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease (including myocardial infarction)
This medication helps reduce the risk of cardiovascular-related death, myocardial infarction, and stroke in adult patients at high risk of cardiovascular diseases, such as coronary heart disease, diabetes, peripheral vascular disease, and stroke. It is also used to reduce the risk of complications following coronary and non-coronary vascular interventions. In the treatment of hyperlipidemia, it contributes to maintaining a healthy lipid balance by controlling blood cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Particularly, it effectively lowers cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia when used in conjunction with dietary modification. This medication plays an important role in protecting patients' health by preventing and improving cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a daily dose of 20 mg of this medicine may provide the maximum reduction in cholesterol levels. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is used concomitantly in patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is used concomitantly in patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is used concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start treatment at 5 mg daily and monitor carefully.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose for each patient as appropriate according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication is primarily used to lower blood cholesterol levels by inhibiting an enzyme involved in cholesterol production in the liver. When taking this medication, there may be muscle-related abnormalities, so if symptoms like muscle pain or weakness occur, consult a doctor immediately. The risk of serious muscle damage, such as myopathy or rhabdomyolysis, can increase, especially when taking high doses or in conjunction with certain drugs. As it may affect liver function, this medication is not recommended for individuals with liver disease or elevated liver enzymes. Also, pregnant or potentially pregnant women and breastfeeding women should not take this medication. Taking this medication with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and HIV treatments can increase the drug concentration and the risk of side effects. Therefore, it is crucial to inform the doctor if you are taking any of these medications, as co-administration may need to be avoided or dosage adjustments may be necessary. Special caution is required for alcohol abusers, patients with poor kidney function, and patients with hypothyroidism when taking this medication. While taking this medication, avoid combining it with grapefruit juice or certain drugs, and always inform your doctor or pharmacist about this medication when starting new drugs. Elderly patients and children also require dosage adjustments and careful monitoring, and this medication is not to be used in children under 10 years. Regular monitoring of liver function tests and muscle-related tests is recommended during treatment, and consult healthcare providers if any unusual symptoms occur. Possible side effects of this medication include dyspepsia, headache, constipation, and muscle pain, and in severe cases, hepatitis, muscle damage, and allergic reactions may occur. In the event of an overdose, seek appropriate treatment immediately, and it is important to store this medication out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain a storage temperature in a range of 1 to 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness.
Brownish yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.